4-Methylpyridine → 2-Pyridazin-4-yl-1-[4-(quinolin-2-ylmethoxy)-phenyl]-ethanone
반응식
[N:1]1C=[CH:5][C:4]([CH2:7][C:8]([C:10]2[CH:15]=[CH:14][C:13]([O:16][CH2:17][C:18]3[CH:27]=[CH:26][C:25]4[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=4)[N:19]=3)=[CH:12][CH:11]=2)=[O:9])=[CH:3][CH:2]=1.[N:28]1C=CC(C)=CC=1>>[N:1]1[CH:2]=[CH:3][C:4]([CH2:7][C:8]([C:10]2[CH:11]=[CH:12][C:13]([O:16][CH2:17][C:18]3[CH:27]=[CH:26][C:25]4[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=4)[N:19]=3)=[CH:14][CH:15]=2)=[O:9])=[CH:5][N:28]=1참가 물질
3
실험 절차
Following the procedure for the preparation of 2-pyridin-4-yl-1-[4-(quinolin-2-ylmethoxy)-phenyl]-ethanone but substituting 4-methyl pyridazine for 4-picoline provided the title compound. 1H NMR (400 MHz, CDCl3) δ 9.12 (d, J=5.4 Hz, 1 H), 9.08 (d, J=8.7 Hz, 2.1 H), 8.20 (d, J=8.3 Hz, 1H), 8.07 (d, J=8.3 Hz, 1 H), 7.96 (m, 2 H), 7.83 (d, J=7.9 Hz, 1 H), 7.76 (m, 1 H), 7.62 (d, J=8.3 Hz, 1 H), 7.55 (m, 1 H) 7.38 (dd, J=5.4, 2.5 Hz, 1H), 7.09 (m, 2H), 5.44 (s, 2H) 4.23 (s, 2H); MS: (M+H m/z=356.2).
출처 및 근거
- ORD 기록
- ord-81c1843099a64b74adc3fd95d4d1b605
- 출처 데이터셋
- uspto-grants-2008_09